Hung Ka Kung
Directeur/Membre du Conseil chez ZERO2IPO HOLDINGS INC.
Postes actifs de Hung Ka Kung
Sociétés | Poste | Début | Fin |
---|---|---|---|
ZERO2IPO HOLDINGS INC. | Directeur/Membre du Conseil | 29/05/2020 | - |
Vcanbio Cell & Gene Engineering Corp.
Vcanbio Cell & Gene Engineering Corp. Miscellaneous Commercial ServicesCommercial Services Vcanbio Cell & Gene Engineering Corp. develops and stores cord blood hematopoietic stem cells. | Président | 01/12/2018 | - |
Zero2ipo Consulting Group Co. Ltd. | Directeur/Membre du Conseil | 01/02/2017 | - |
Wealth Strategy Holding Ltd. | Directeur/Membre du Conseil | - | - |
Pan Asia Information Services Ltd. | Directeur/Membre du Conseil | 01/07/1994 | - |
Fortune Time Technology Ltd. | Président | 01/04/2002 | - |
Historique de carrière de Hung Ka Kung
Anciens postes connus de Hung Ka Kung
Sociétés | Poste | Début | Fin |
---|---|---|---|
GENETRON HOLDINGS LIMITED | Fondateur | - | - |
Beijing Watchdata Technologies Co. Ltd. | Fondateur | - | - |
SHANGHAI FULLHAN MICROELECTRONICS CO., LTD. | Directeur/Membre du Conseil | 01/04/2013 | - |
Formation de Hung Ka Kung
Huazhong University of Science & Technology | Undergraduate Degree |
Statistiques
Internationale
Chine | 6 |
Hong Kong | 4 |
Îles Cayman | 3 |
Opérationnelle
Director/Board Member | 5 |
Chairman | 2 |
Founder | 2 |
Sectorielle
Finance | 2 |
Consumer Services | 2 |
Electronic Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
ZERO2IPO HOLDINGS INC. | Finance |
SHANGHAI FULLHAN MICROELECTRONICS CO., LTD. | Electronic Technology |
Entreprise privées | 7 |
---|---|
Wealth Strategy Holding Ltd. | |
Vcanbio Cell & Gene Engineering Corp.
Vcanbio Cell & Gene Engineering Corp. Miscellaneous Commercial ServicesCommercial Services Vcanbio Cell & Gene Engineering Corp. develops and stores cord blood hematopoietic stem cells. | Commercial Services |
Genetron Holdings Ltd.
Genetron Holdings Ltd. Medical/Nursing ServicesHealth Services Genetron Holdings, Ltd. engages in precision oncology. It provides cancer molecular profiling by using technologies in molecular biology and data science to transform cancer treatment. It products and services include diagnosis and monitoring through both LDT and IVD products. Its LDT portfolio consists of both specifically designed focused and comprehensive gene panel testing services. It also develops liver cancer early screening products. The company was founded by Si Zhen Wang, Hai Yan, and Wei Wu He in 2015 and is headquartered in Beijing, China. | Health Services |
Zero2ipo Consulting Group Co. Ltd. | |
Beijing Watchdata Technologies Co. Ltd. | |
Pan Asia Information Services Ltd. | |
Fortune Time Technology Ltd. |
- Bourse
- Insiders
- Hung Ka Kung
- Expérience